A new variant of Virta-Flaneurazine, VF betaAR, has been successfully developed. It is produced from the skin secretions of bio- engineered and programmed hybrid Bufo toads. When areas of these toads are touched, the resulting reaction causes a wandering viewer to see things appearing from virtual worlds and other sources on the Internet. This appears to be an integrated and compelling conscious experience. This perception can be simultaneously viewed on an iPhone or Android device using Layars or other augmented reality software.
Because of the surprising success of our first test at MoMA, October 9, we will be entering a wider human test phase November 14 at BETA Spaces 2010 in Bushwick, Brooklyn (NY). The drug tests will be part of an art program, Bushwick AR Intervention. Though the parameters of the effects are somewhat limited at this point, this appears to be a very important step towards complete integration.